Home › Compare › NXLIW vs FCPT

NXLIW vs FCPT: Dividend Comparison 2026

NXLIW yields 14492.75% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NXLIW wins by $2154305968474146048.00M in total portfolio value
10 years
NXLIW
NXLIW
● Live price
14492.75%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2154305968474146048.00M
Annual income
$2,125,456,416,598,225,800,000,000.00
Full NXLIW calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — NXLIW vs FCPT

📍 NXLIW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNXLIWFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NXLIW + FCPT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NXLIW pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NXLIW
Annual income on $10K today (after 15% tax)
$1,231,884.06/yr
After 10yr DRIP, annual income (after tax)
$1,806,637,954,108,492,000,000,000.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, NXLIW beats the other by $1,806,637,954,108,492,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NXLIW + FCPT for your $10,000?

NXLIW: 50%FCPT: 50%
100% FCPT50/50100% NXLIW
Portfolio after 10yr
$1077152984237073024.00M
Annual income
$1,062,728,208,299,112,900,000,000.00/yr
Blended yield
98.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

NXLIW
No analyst data
Altman Z
-32.8
Piotroski
3/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NXLIW buys
0
FCPT buys
0
No recent congressional trades found for NXLIW or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNXLIWFCPT
Forward yield14492.75% ✓6.05%
Annual dividend / share$2.00 ✓$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$2154305968474146048.00M ✓$49.1K
Annual income after 10y$2,125,456,416,598,225,800,000,000.00 ✓$5,775.28
Total dividends collected$2152396274958258432.00M ✓$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: NXLIW vs FCPT ($10,000, DRIP)

YearNXLIW PortfolioNXLIW Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$1,459,975$1,449,275.36$11,401$700.92+$1.45M → NXLIW
2$199,310,428$197,748,254.41$13,064$864.84+$199.30M → NXLIW
3$25,443,037,058$25,229,774,899.52$15,051$1,072.48+$25443.02M → NXLIW
4$3,037,238,126,713$3,010,014,077,061.22$17,442$1,337.22+$3037238.11M → NXLIW
5$339,060,630,986,506$335,810,786,190,923.60$20,340$1,677.08+$339060630.97M → NXLIW
6$35,398,380,947,675,984$35,035,586,072,520,424.00$23,880$2,116.57+$35398380947.65M → NXLIW
7$3,456,345,235,755,821,000$3,418,468,968,141,808,000.00$28,241$2,689.36+$3456345235755.79M → NXLIW
8$315,645,840,624,138,850,000$311,947,551,221,880,100,000.00$33,660$3,442.07+$315645840624138.75M → NXLIW
9$26,962,198,014,878,525,000,000$26,624,456,965,410,697,000,000.00$40,456$4,439.95+$26962198014878524.00M → NXLIW
10$2,154,305,968,474,146,000,000,000$2,125,456,416,598,225,800,000,000.00$49,063$5,775.28+$2154305968474146048.00M → NXLIW

NXLIW vs FCPT: Complete Analysis 2026

NXLIW — Stock

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.

Full NXLIW Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this NXLIW vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NXLIW vs SCHDNXLIW vs JEPINXLIW vs ONXLIW vs KONXLIW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.